Taysha Gene Therapies
TSHA
#7372
Rank
NZ$0.51 B
Marketcap
$2.51
Share price
5.63%
Change (1 day)
-2.09%
Change (1 year)

Taysha Gene Therapies (TSHA) - Cash on Hand

Cash on Hand as of June 2024 : NZ$0.28 Billion

According to Taysha Gene Therapies's latest financial reports the company has NZ$0.28 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Taysha Gene Therapies - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$0.13 B-36.59%
2021-12-31NZ$0.21 B-37.31%
2020-12-31NZ$0.34 B
2019-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.47 B 65.80%๐Ÿ‡บ๐Ÿ‡ธ USA